title: Epidemiological study on cancer prevention by ginseng: are all kinds of cancers preventable by ginseng?
abstract: In the light of experimental results, two case-control studies and one cohort study in a population of ginseng cultivation area were conducted to confirm whether ginseng has any anticarcinogenic effect on human cancers. All participants were interviewed using a standardised questionnaire to obtain the information on demographics, cigarette smoking, alcohol consumption and ginseng intake. In 905 pairs case-control study, 62% had a history of ginseng intake compared to 75% of the controls, a statistically significant difference (p<0.01). The odds ratio (OR) for cancer in relation to ginseng intake was 0.56. In extended case-control study with 1987 pairs, the ORs for cancer were 0.37 in fresh ginseng extract users, 0.57 in white ginseng extract users, 0.30 in white ginseng extract users, 0.30 in white ginseng powder users, and 0.20 in red ginseng users. Those who took fresh ginseng slices, fresh ginseng juice, and white ginseng tea, however, did not show decrease in the risk. Overall, the risk decreased as the frequency and duration of ginseng intake increased. With respect to the site of cancer, the ORs for cancers of the lip, oral cavity, pharynx, esophagus, stomach, colorectum, liver, pancreas, larynx, lung and ovary were significantly reduced by ginseng intake. Smokers with ginseng intake showed lower ORs for cancers of lung, lip, oral cavity and pharynx and liver than those without ginseng intake. In 5 yr follow- up cohort study conducted in the ginseng cultivation area, Kangwha-eup, ginseng intakers had significantly lower risk than non-intakers. As for the type of ginseng, cancer risk significantly decreased among intakers of fresh ginseng extract, alone or together with other ginseng preparations. Among 24 red ginseng intakers, no cancer death occurred during the follow-up period. The risk for stomach and lung cancers was significantly reduced by ginseng intake, showing a statistically significant dose-response relationship in each follow-up year. In conclusion, Panax ginseng C.A. Meyer has been established as non-organ specific cancer preventive, having dose response relationship. These results warrant that ginseng extracts and its synthetic derivatives should be examined for their preventive effect on various types of human cancers.
authors.affiliation: Laboratory of Experimental Pathology, Korea Cancer Center Hospital, Seoul, Korea. tkyun@nuri.net
authors.forename: T K
authors.initials: TK
authors.lastname: Yun
authors.forename: S Y
authors.initials: SY
authors.lastname: Choi
authors.forename: H Y
authors.initials: HY
authors.lastname: Yun
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D016022:Case-Control Studies; D015331:Cohort Studies; D006801:Humans; D007723:Korea / Q000453:epidemiology; D009369:Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D005894:Panax; D018517:Plant Roots; D011159:Population Surveillance
chemical_list: D000972:Antineoplastic Agents, Phytogenic